Fundraising FoxVesiflo
Redmond, US · Founded 2012 · Delaware corporation
Find your way into Vesiflo
Sign up to see every warm intro you have to Vesiflo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vesiflo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vesiflo manufactures medical devices for urinary retention treatment, specifically targeting women with permanent conditions. The company's primary product, the inFlow Voiding Prosthesis, is designed as a safer alternative to existing bladder drainage solutions.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 5 rounds · 2015–2021
▶$87.5KraisedMar 2021 · 3 investors · Other Health CareRule 506(b)
▶$87.5KraisedMar 2021 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terrance MooreExecutive Officer
- Thomas Van NoyDirector
- Susan RobinsonExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- John SullivanExecutive Officer
- Offering amount
- $600K
- Amount sold
- $87.5K
- Minimum investment
- $12.5K
- Proceeds to insiders
- $1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125KraisedMay 2019 · 4 investors · Other Health CareRule 506(b)
▶$125KraisedMay 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terrance MooreExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- John SullivanExecutive Officer
- Susan RobinsonExecutive Officer
- Thomas Van NoyDirector
- Offering amount
- $1M
- Amount sold
- $125K
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMay 2017 · 55 investors · Other Health CareRule 506(c)
▶$3.3MraisedMay 2017 · 55 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Wayne DeMeesterDirector
- John SullivanExecutive Officer
- Thomas Loran Van NoyExecutive Officer
- Kevin ConnollyExecutive Officer, Director
- Terrance MooreExecutive Officer
- Susan RobinsonExecutive Officer
- Offering amount
- $7M
- Amount sold
- $3.3M
- Minimum investment
- $25K
- Sales commissions
- $300K
- Proceeds to insiders
- $605K
- Placement agents
- Adam Fountain
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06c
▶$50KraisedJan 2016 · 1 investors · ManufacturingRule 506(b)
▶$50KraisedJan 2016 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ConnollyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2MraisedFeb 2015 · 26 investors · ManufacturingRule 506(b)
▶$2MraisedFeb 2015 · 26 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Terrence MooreExecutive Officer
- Loran Van NoyExecutive Officer
- Wayne DeMeesterExecutive Officer
- John W SullivanExecutive Officer
- Kevin M ConnollyExecutive Officer, Director
- Susan RobinsonExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $5K
- Sales commissions
- $27.5K
- Proceeds to insiders
- $300K
- Placement agents
- Broadmark Capital LLC
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
GenhealthGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
CarepatronCarepatron provides practice management and clinical workflow software for healthcare clinicians. The platform handles scheduling, patient documentation, billing, and payments in a single application, targeting medical practitioners globally.
GovdeliveryProvides the Government Experience Cloud (GXC) and Destination Experience Cloud (DXC) platforms, which offer AI-driven, data-based tools and services for public sector digital experiences. Serves governments and destination marketing organizations (DMOs) to help them reach and serve constituents, communities, and destinations.
Companies working in the same space as Vesiflo.
In the news
Frequently asked questions
- What does Vesiflo do?
- Vesiflo manufactures medical devices for urinary retention treatment, specifically targeting women with permanent conditions. The company's primary product, the inFlow Voiding Prosthesis, is designed as a safer alternative to existing bladder drainage solutions.
- How much funding has Vesiflo raised?
- Vesiflo has disclosed $5.6M raised across 5 rounds.
- Where is Vesiflo headquartered?
- Vesiflo is headquartered in Redmond, US.